168 related articles for article (PubMed ID: 8960665)
1. [Acute myelogenous leukemia with ins(21;8) expressing AML-1-MTG8 fusion transcript].
Kazama H; Aoyama M; Sameshima Y; Teramura M; Masuda M; Motoji T; Okada M; Mizoguchi H
Rinsho Ketsueki; 1996 Nov; 37(11):1297-302. PubMed ID: 8960665
[TBL] [Abstract][Full Text] [Related]
2. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
3. [Acute myelocytic leukemia with ins(21;8)(q22;q13q22) presenting with AML1/MTG8 chimeric mRNA].
Yamazaki E; Ogawa K; Harano H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2000 Sep; 41(9):745-9. PubMed ID: 11070937
[TBL] [Abstract][Full Text] [Related]
4. [Rearrangements and fusion gene of AML1 and MTG8 in acute myeloid leukemia M2b].
Wang J; Xiao Z; Hao Y
Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):399-402, 445. PubMed ID: 7553157
[TBL] [Abstract][Full Text] [Related]
5. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
Kasashima K; Sakota E; Kozu T
Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
[TBL] [Abstract][Full Text] [Related]
6. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
[TBL] [Abstract][Full Text] [Related]
7. Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogenous leukemia.
Maruyama F; Yang P; Stass SA; Cork A; Freireich EJ; Lee MS; Chang KS
Cancer Res; 1993 Oct; 53(19):4449-51. PubMed ID: 8402610
[TBL] [Abstract][Full Text] [Related]
8. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
[TBL] [Abstract][Full Text] [Related]
9. Ribozymes cleave the AML1/MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21).
Matsushita H; Kobayashi H; Mori S; Kizaki M; Ikeda Y
Biochem Biophys Res Commun; 1995 Oct; 215(2):431-7. PubMed ID: 7487974
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8.
Matsushita H; Kizaki M; Kobayashi H; Muto A; Ikeda Y
Br J Cancer; 1999 Mar; 79(9-10):1325-31. PubMed ID: 10188872
[TBL] [Abstract][Full Text] [Related]
11. Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21).
Nucifora G; Dickstein JI; Torbenson V; Roulston D; Rowley JD; Vardiman JW
Leukemia; 1994 Sep; 8(9):1533-8. PubMed ID: 7522291
[TBL] [Abstract][Full Text] [Related]
12. Detection and subcellular localization of an AML1 chimeric protein in the t(8;21) positive acute myeloid leukemia.
Sacchi N; Schiaffonati L; Magnani I; Pappalardo C; Hughes AJ; Darfler M; Hoogeveen AT
Oncogene; 1996 Jan; 12(2):437-44. PubMed ID: 8570222
[TBL] [Abstract][Full Text] [Related]
13. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia.
Maruyama F; Stass SA; Estey EH; Cork A; Hirano M; Ino T; Freireich EJ; Yang P; Chang KS
Leukemia; 1994 Jan; 8(1):40-5. PubMed ID: 7507193
[TBL] [Abstract][Full Text] [Related]
14. The 8;21 translocation in leukemogenesis.
Peterson LF; Zhang DE
Oncogene; 2004 May; 23(24):4255-62. PubMed ID: 15156181
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and cytological features of acute myelogenous leukemia with 8; 21 chromosome translocation].
Harada H; Nasu K; Harada Y; Niki Y; Tomono N; Akasaka K; Hoshizaki H; Edamura S; Kawamura Y; Ito Y
Rinsho Ketsueki; 1991 Jul; 32(7):751-7. PubMed ID: 1920838
[TBL] [Abstract][Full Text] [Related]
16. Quantitative nested reverse transcriptase PCR vs. real-time PCR for measuring AML1/ETO (MTG8) transcripts.
Takenokuchi M; Yasuda C; Takeuchi K; Nakamachi Y; Mukai M; Kondo S; Kumagai S; Saigo K; Murayama T; Koizumi T; Tatsumi E
Clin Lab Haematol; 2004 Apr; 26(2):107-14. PubMed ID: 15053804
[TBL] [Abstract][Full Text] [Related]
17. [Disappearance of residual disease confirmed by RT-PCR following induction chemotherapy in two hypoplastic leukemia patients with t(8;21)].
Sawada M; Tsurumi H; Yamada T; Hara T; Oyama M; Moriwaki H
Rinsho Ketsueki; 1999 Apr; 40(4):311-7. PubMed ID: 10355140
[TBL] [Abstract][Full Text] [Related]
18. [AML1 gene rearrangements, but no 8;21 translocation in a child with acute myeloblastic leukemia (M2)].
Oka T; Suzuki Y; Shimizu S; Sakata Y; Azuma H; Kaneko Y
Rinsho Ketsueki; 1994 Jan; 35(1):69-74. PubMed ID: 8139104
[TBL] [Abstract][Full Text] [Related]
19. Variant translocation t(2;21;8)(q36;q22;q22) with RUNX1/CBFA2T1 (AML1/ETO) transcript in a case of acute myelogenous leukemia.
Hsiao HH; Sashida G; Kodama A; Fukutake K; Ohyashiki K
Cancer Genet Cytogenet; 2005 May; 159(1):96-7. PubMed ID: 15860366
[No Abstract] [Full Text] [Related]
20. Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: sequential cytogenetic and molecular analyses.
Nawata R; Shinohara K; Yamada T; Takahashi T; Katsuki K; Takeda K; Kameda N; Ariyoshi K; Ota I; Muraki K
Int J Hematol; 2000 Jun; 71(4):353-8. PubMed ID: 10905055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
